STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 101 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $2,000 | -60.0% | 500 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $5,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $8,000 | +33.3% | 500 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $6,000 | +20.0% | 500 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $8,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $8,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $7,000 | +16.7% | 500 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $6,000 | +20.0% | 500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $4,000 | -81.8% | 500 | -75.0% | 0.00% | -88.9% |
Q3 2016 | $22,000 | +266.7% | 2,000 | +300.0% | 0.01% | +350.0% |
Q2 2015 | $6,000 | -79.3% | 500 | -75.0% | 0.00% | -80.0% |
Q1 2015 | $29,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |